Apexian Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2017
Total raised
- $2.5M
Investors
- 4
About Apexian Pharmaceuticals
Apexian Pharmaceuticals, Inc.Founded in 2007 and headquartered in Indianapolis, Indiana, Apexian Pharmaceuticals, Inc. specializes in drug development targeting the APE1/Ref-1 redox protein.Apexian Pharmaceuticals' core product, APX3330, is a novel drug candidate targeting the APE1/Ref-1 redox protein, linked to various cancers and inflammatory conditions. It has shown substantial anti-cancer and anti-inflammatory effects in pre-clinical studies, with a current clinical development program including a Phase 2 trial for treating diabetic retinopathy.The exact revenue details for Apexian Pharmaceuticals are not specified. The company's business model is centered on clinical trials and partnerships with healthcare providers, involving B2B transactions with hospitals and medical research institutions for the development and distribution of APX3330. The company aims to initiate trials for new products targeting additional indications while exploring opportunities to enter broader international markets beyond North America. This expansion strategy is anticipated to be implemented in the next few years, aligning with their commitment to address unmet medical needs in oncology and inflammatory diseases.
Who invested in Apexian Pharmaceuticals
4 investors across 3 rounds
See all investors in Apexian Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apexian Pharmaceuticals
Who invested in Apexian Pharmaceuticals?
Apexian Pharmaceuticals has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apexian Pharmaceuticals raised?
Apexian Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Apexian Pharmaceuticals last raise money?
Apexian Pharmaceuticals's most recent round on record is a Series A, in Nov 2017.
What does Apexian Pharmaceuticals do?
Apexian Pharmaceuticals is a pharmaceuticals company.
Where is Apexian Pharmaceuticals headquartered?
Apexian Pharmaceuticals is headquartered in Indianapolis, US.
Which VCs invest in companies like Apexian Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Apexian Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Apexian Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.